Portfolio company
Cytecom
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Cytecom develops optical electrophysiology devices for rapid detection of viable bacteria and antimicrobial susceptibility testing for healthcare providers and clinical laboratories.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CytoTronics
CytoTronics produces semiconductor-based microplate systems for real-time, single-cell resolution electrophysiological imaging to assist pharmaceutical researchers in drug discovery and cell biology.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Pattern Biosciences
This company develops single-cell microbiology diagnostic systems for rapid bacterial identification and antibiotic susceptibility testing for clinical laboratories and hospital settings.
Resistell
This company develops nanomotion-based diagnostic platforms for rapid antibiotic susceptibility testing to help healthcare providers and laboratories treat bloodstream infections.
Astratus
Astratus develops rapid microfluidic diagnostic tests and prototype instrument readers for antimicrobial susceptibility testing in human and veterinary clinical laboratories.
SoundCell
SoundCell develops graphene-based biosensor platforms for rapid antibiotic susceptibility testing to help healthcare professionals and diagnostic laboratories identify effective treatments for bacterial infections.
FluoretiQ Limited
This company develops rapid point-of-care diagnostic tests that identify bacterial infections and antibiotic sensitivity for clinicians and veterinarians.
Pattern Diagnostics
This company develops single-cell microbiology systems for rapid pathogen identification and antibiotic susceptibility testing, serving hospital and clinical microbiology laboratories.
